1 Min Read
Jan 8 (Reuters) -
* ASCENTAGE PHARMA ANNOUNCES ACCEPTANCE OF IND APPLICATION BY CHINA FDA FOR CLINICAL STUDY OF NOVEL IAP INHIBITOR TO TREAT HEPATITIS B INFECTION Source text for Eikon:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.